person

Ana Célia C. C. D. S.

Country
Portugal
Department
Serviço de Gastroenterologia

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 11 partner sites.

Specializations

Inflammatory Bowel Disease

Focused on the management of chronic intestinal inflammation, the investigator addresses therapeutic strategies for Crohn's Disease and Ulcerative Colitis.

  • Biologic agents for disease remission
  • Targeted small molecules for induction and maintenance
  • Biomarker‑driven treatment personalization

Research integrates endoscopic outcomes and quality‑of‑life metrics to advance patient‑centered care.

Liver and Metabolic Disorders

Investigates therapeutic options for Alpha‑1 Antitrypsin Deficiency‑Associated Liver Disease and metabolic liver conditions such as Non‑Alcoholic Steatohepatitis.

  • Antifibrotic therapies
  • Gene‑editing approaches
  • Metabolic modulation strategies

Emphasis on liver histology improvement and metabolic profile normalization.

Gastrointestinal Oncology

Dedicated to malignant diseases of the upper gastrointestinal tract, including Gastric Adenocarcinoma and Gastroesophageal Junction Cancer.

  • Targeted HER2 and FGFR2b therapies
  • Immunotherapy combinations
  • Neoadjuvant and adjuvant treatment optimization

Outcomes focus on tumor response, surgical resectability, and survival.

Neurological Degeneration

Explores disease‑modifying interventions for neurodegenerative disorders such as Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis.

  • Amyloid‑targeting agents
  • Alpha‑synuclein modulation
  • Immune‑based therapies

Clinical endpoints include cognitive function, motor scores, and relapse rate.

Cardiovascular and Renal Disease

Addresses cardiovascular risk and renal impairment, covering conditions like Acute Coronary Syndrome, Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease.

  • Antithrombotic strategies
  • Lipid‑lowering agents
  • Renal protective therapies

Research aligns cardiovascular event reduction with preservation of renal function.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.